| Log in

Biomark Capital-backed Strand Life Sciences may float IPO by 2016

21 May, 2014

Bangalore-based Strand Life Sciences Pvt Ltd, which focuses on clinical genomics and research in biotechnology, aims to go for public listing by 2016, the chairman of the company t ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Exclusive: Strand Life Sciences close to raising $20M

Exclusive: Strand Life Sciences close to raising $20M

Raghuvir Badrinath 3 years ago
Bangalore-based clinical genomics and biotech research firm Strand Life Sciences...
Strand Life Sciences raises Series B round from life sciences-focused investor Burrill

Strand Life Sciences raises Series B round from life sciences-focused investor Burrill

TEAM VCC 5 years ago
Burrill & Company, a diversified global financial services firm focused on...
Strand Life Sciences to list on NASDAQ via reverse merger

Strand Life Sciences to list on NASDAQ via reverse merger

Joseph Rai 2 years ago
Bangalore-based Strand Life Sciences Pvt Ltd, which focuses on clinical genomics...
No Comments

Biomark Capital-backed Strand Life Sciences may float IPO by 2016

Powered by WordPress.com VIP